A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday – PR Newswire Leave a Comment / Mega Deals / By A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday PR Newswire Source: news.google.com
